common, benign (noncancerous) tumors that grow in the muscle of the uterus, or womb. Fibroids often cause no symptoms and need no treatment, and they usually shrink after menopause. But sometimes fibroids cause heavy bleeding or pain, and require treatment.
fibrous, non-cancerous, growths within the uterus
Benign (noncancerous) growths that develop from the cells that make up the muscle of the uterus and form on the inside of the uterus, on its outer surface, or within the uterine wall itself. They are also called leiomyomas or myomas.
Benign tumors of fibrous and muscular tissue that develop in the muscle wall of the uterus.
Fibroids are the most frequently seen tumors of the female reproductive system. Also known as uterine myomas, leiomyomas, or fibromas, they are firm, compact tumors that are made of smooth muscle cells and fibrous connective tissue that develop in the uterus. In more than 99% of cases they are benign (non-cancerous). They may range in size from the size of a pea to the size of a softball or small grapefruit. Some women never have symptoms, the most common of which are: heavy or prolonged menstrual periods; abnormal bleeding between menstrual periods; pelvic pain; frequent urination; low back pain; pain during intercourse; a firm mass, often located near the middle of the pelvis, which can be felt by a physician.
Abnormal, benign (noncancerous) growths of muscle within the wall of a woman's uterus
Benign (non-cancerous) masses located in the uterus or in the uterine wall
non-cancerous growths in the wall of the uterus. Fibroids vary in size from very small to eight or more inches in diameter. Usually more than one fibroid is present. Fibroids can cause many symptoms (e.g., heavy bleeding, pain or incontinence) or not cause any problems at all. Fibroids do not turn into cancer.
Uterine fibroids (leiomyomata, singular leiomyoma) are the most common neoplasm in females, and may affect about 25 % of white and 50% of black women during the reproductive years. Uterine Fibroids may be removed by NSAIDs, a hysterectomy, hormonal therapy, a myomectomy, or uterine artery embolization.